Thermo Fisher Scientific Inc. (TMO) Cash Flow Statement
Thermo Fisher Scientific Inc. (TMO) generated $9.0B of operating cash flow over the twelve months to 2026-06-30, spent $1.7B on capital expenditure and had free cash flow of $7.3B, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
TMOThermo Fisher Scientific Inc.Follow TMO — free
—
Price chart with a free account
- Market cap
- 249.1B
- P/E TTM
- 36.2
- Dividend yield
- 0.3%
- 52-week
- —
- Next earnings
- 27 Jan, in 95 days
| Line | FY2009 Dec 09 | FY2010 Dec 10 | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1.66 | 1.50 | 1.69 | 2.04 | 2.01 | 2.62 | 2.94 | 3.26 | 4.01 | 4.54 | 4.97 | 8.29 | 9.31 | 9.15 | 8.41 | 8.67 | 7.82 | 9.01 | |
| Capital expenditure | 0.20 | 0.25 | 0.26 | 0.32 | 0.28 | 0.43 | 0.42 | 0.44 | 0.51 | 0.76 | 0.93 | 1.47 | 2.52 | 2.24 | 1.48 | 1.40 | 1.53 | -1.70 | |
| Free cash flow | 1.46 | 1.25 | 1.43 | 1.72 | 1.73 | 2.19 | 2.52 | 2.81 | 3.50 | 3.79 | 4.05 | 6.82 | 6.79 | 6.91 | 6.93 | 7.27 | 6.29 | 7.32 | |
| Dividends paid | — | — | — | 0.14 | 0.22 | 0.23 | 0.24 | 0.24 | 0.24 | 0.27 | 0.30 | 0.34 | 0.40 | 0.46 | 0.52 | 0.58 | 0.64 | — | |
| Share repurchases | 0.41 | 1.01 | 1.34 | 1.15 | 0.09 | 0.00 | 0.50 | 1.25 | 0.75 | 0.50 | 1.50 | 1.50 | 2.00 | 3.00 | 3.00 | 4.00 | 3.00 | — | |
| Stock-based compensation | 0.07 | 0.08 | 0.08 | 0.08 | 0.09 | 0.12 | 0.13 | 0.13 | 0.16 | 0.18 | 0.18 | 0.20 | 0.23 | 0.31 | 0.28 | 0.30 | 0.31 | — |
USD billions · SEC XBRL
Thermo Fisher Scientific Inc. — questions
- What is Thermo Fisher Scientific Inc.'s operating cash flow?
- $9.0B over the twelve months to 2026-06-30.
- How much does Thermo Fisher Scientific Inc. spend on capital expenditure?
- $1.7B over the twelve months to 2026-06-30.
- What is Thermo Fisher Scientific Inc.'s free cash flow?
- $7.3B over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Thermo Fisher Scientific Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.